CPK-MB Ratio
The CPK-MB ratio (CK-MB/total CK) is calculated by dividing CK-MB mass (in ng/mL or μg/L) by total CK activity (in U/L), expressed as ng/U, and is used to distinguish myocardial injury from skeletal muscle damage—with a ratio ≥80 ng/U strongly suggesting cardiac origin.
What the Ratio Represents
The CPK-MB ratio exploits the differential tissue distribution of CK-MB between cardiac and skeletal muscle. While CK-MB is highly concentrated in myocardium (averaging 202 ng/U of total CK), skeletal muscles contain much lower relative amounts (0.9-44 ng/U, varying by muscle type) 1. This fundamental biochemical difference allows the ratio to differentiate the source of elevated CK-MB.
Clinical Application and Interpretation
Diagnostic Cutoffs
- Myocardial infarction: Ratio ≥80 ng/U indicates cardiac necrosis 1
- Skeletal muscle injury: Ratios typically <38 ng/U, averaging 7 ng/U in trauma patients and 18 ng/U in burn patients 1
- Historical percentage-based cutoff: CK-MB >4-6% of total CK was previously used 2, 3, 4, though the ng/U ratio provides superior discrimination
Key Clinical Scenarios
When the ratio helps:
- Distinguishing MI from skeletal muscle trauma, burns, or rhabdomyolysis
- Evaluating patients with elevated total CK from non-cardiac causes
- In acute MI, ratios typically exceed 200 ng/U, with all patients showing at least one value ≥110 ng/U within 8-32 hours of symptom onset 1
When the ratio fails:
- Muscular diseases (myositis, muscular dystrophy): CK-MB mass remains persistently elevated even without cardiac involvement, making the ratio unreliable 5
- Non-cardiac trauma: The time-dependent release of CK and CK-MB from injured skeletal muscle creates false-positive results, as the isoenzymes don't release simultaneously 6
- NSTEMI vs unstable angina: Recent data shows the ratio has poor discriminatory value (sensitivity 51.5%, specificity 57.3%) between these conditions 7
Critical Limitations and Modern Context
The Troponin Era
Cardiac troponin has superseded CK-MB as the preferred biomarker for myocardial injury 8. The NACB guidelines explicitly state that cardiac troponin (measured at the 99th percentile) is the gold standard, with CK-MB relegated to second-line status only when troponin is unavailable 8.
Why Troponin Wins
- Superior cardiac specificity: Troponin I and T are unique to cardiac myocytes, unlike CK-MB which comprises 1-3% of skeletal muscle CK 8
- Better discrimination: Troponin identifies myocardial injury when CK-MB is normal or minimally elevated 8
- Risk stratification: Elevated troponin with normal CK-MB identifies high-risk patients previously classified as unstable angina 8
When CK-MB Retains Value
Despite troponin's dominance, CK-MB (measured by mass assay, not activity) has specific advantages 8:
- Detecting reinfarction: CK-MB's shorter elevation duration (24-36 hours vs 4-14 days for troponin) allows earlier detection of recurrent MI
- Timing of infarction: The characteristic rise and fall pattern helps date the event
Practical Algorithm
For suspected myocardial injury:
- First-line: Measure cardiac troponin (serial measurements at presentation and 3-6 hours later)
- If troponin unavailable: Use CK-MB mass (not activity assays) 8
- If CK-MB elevated with normal troponin: Seek alternative explanations (skeletal muscle injury, chronic conditions) 8
- Calculate CPK-MB ratio only when:
- Distinguishing cardiac from skeletal muscle source of CK-MB elevation
- Patient has trauma, burns, or other skeletal muscle injury
- Ratio ≥80 ng/U supports cardiac origin; <38 ng/U suggests skeletal muscle
Common Pitfalls
- Don't use CK-MB activity assays—mass assays offer superior analytical and diagnostic performance 8
- Don't rely on the ratio in muscular diseases—persistently elevated CK-MB mass occurs without cardiac involvement 5
- Don't use the ratio to differentiate NSTEMI from unstable angina—it lacks adequate sensitivity and specificity 7
- Don't delay treatment waiting for biomarkers if ECG shows diagnostic ST-elevation 8
- Avoid obsolete markers: Total CK, LDH, and AST should not be used for MI diagnosis 8